PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-12.71%
Negative net income growth while BB stands at 127.14%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-11.84%
Negative yoy D&A while BB is 1.14%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-89.55%
Both reduce yoy usage, with BB at -168.43%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-125.00%
Negative yoy inventory while BB is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-64.10%
Both reduce yoy usage, with BB at -100.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
No Data
No Data available this quarter, please select a different quarter.
-22.77%
Both yoy CFO lines are negative, with BB at -143.37%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
22.99%
Lower CapEx growth vs. BB's 100.00%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
-114.38%
Negative yoy purchasing while BB stands at 100.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-9.38%
Both yoy lines negative, with BB at -129.80%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-56.60%
We reduce yoy invests while BB stands at 1.76%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-6.98%
Both yoy lines negative, with BB at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-554.05%
We cut yoy buybacks while BB is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.